Colgate-Palmolive (NYSE:CL – Get Free Report) is projected to post its Q2 2026 results before the market opens on Friday, July 31st. Analysts expect Colgate-Palmolive to post earnings of $0.9470 per share and revenue of $5.3563 billion for the quarter. Interested persons are encouraged to explore the company’s upcoming Q2 2026 earning results page for the latest details on the call scheduled for Friday, July 31, 2026 at 8:30 AM ET.
Colgate-Palmolive (NYSE:CL – Get Free Report) last announced its quarterly earnings results on Friday, May 1st. The company reported $0.97 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.94 by $0.03. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The firm’s quarterly revenue was up 8.4% on a year-over-year basis. During the same period last year, the firm posted $0.91 EPS. On average, analysts expect Colgate-Palmolive to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.
Colgate-Palmolive Price Performance
NYSE:CL opened at $93.75 on Thursday. The firm has a market cap of $75.02 billion, a PE ratio of 36.48, a price-to-earnings-growth ratio of 4.88 and a beta of 0.33. Colgate-Palmolive has a 12 month low of $74.54 and a 12 month high of $99.33. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. The company’s 50-day moving average price is $90.94 and its two-hundred day moving average price is $89.35.
Colgate-Palmolive Dividend Announcement
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the company. Rothschild & Co Redburn set a $100.00 target price on Colgate-Palmolive and gave the stock a “buy” rating in a report on Tuesday, April 21st. JPMorgan Chase & Co. raised their price target on Colgate-Palmolive from $96.00 to $104.00 and gave the company an “overweight” rating in a report on Thursday, July 16th. Citigroup lifted their price objective on Colgate-Palmolive from $105.00 to $110.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Morgan Stanley restated an “overweight” rating on shares of Colgate-Palmolive in a report on Monday, May 4th. Finally, Sanford C. Bernstein started coverage on Colgate-Palmolive in a report on Thursday, June 11th. They issued a “market perform” rating and a $96.00 price target for the company. Twelve investment analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $97.82.
Get Our Latest Stock Report on Colgate-Palmolive
Institutional Inflows and Outflows
Several large investors have recently bought and sold shares of the company. Kemnay Advisory Services Inc. acquired a new stake in shares of Colgate-Palmolive in the 4th quarter valued at $25,000. Triumph Capital Management lifted its stake in shares of Colgate-Palmolive by 62.9% during the fourth quarter. Triumph Capital Management now owns 329 shares of the company’s stock valued at $26,000 after acquiring an additional 127 shares during the period. Jessup Wealth Management Inc bought a new position in Colgate-Palmolive in the fourth quarter valued at about $26,000. Motiv8 Investments LLC bought a new position in Colgate-Palmolive in the fourth quarter valued at about $27,000. Finally, Kelleher Financial Advisors acquired a new stake in Colgate-Palmolive in the third quarter worth about $35,000. Institutional investors and hedge funds own 80.41% of the company’s stock.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- Why SK hynix Could Be the Best AI Chip Stock to Buy Now
- Seagate Technology Stock Surges as Earnings Beat Silences AI Doubters
- Alphabet Is Down 18% From Its High After a Stellar Quarter—Overdone, or More Downside Ahead?
- Why Bloom Energy May Be the Most Important AI Infrastructure Stock
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
